News About: Pharm. Industry
Medium-sized drugmakers hit by poor sales and net profit last year
Overall, medium-sized pharmaceutical firms ranging from 50 to 200 billion in sales suffered from poor revenues and/or earnings last year due chiefly to the government’s anti-rebate measures, according to Yakup Shinmoo...
More strict production hygiene standards eyed
Buildings and facilities used in the manufacture of cephalosporins and cytotoxic agents should be separated from other production areas to minimize potential contamination, according to the Korea Food and Drug Adminis...
New body set to help beleaguered pharmaceutical firms
The Korea Drug Research Association (KDRA) said it will establish a special unit of 50 experts from seven subcommittees, such as industry nurturing strategy, research and development, global standards, marketing and i...
Wholesalers fail in hospital bids
Several wholesalers’ bid to supply medicines to Youngnam University Hospital fell shot yet after failing to meet the suggested prices of the hospital, sources said on March 9.
A wholesaler did not hide a sense of d...
Drugmakers to recruit new employees
This month is expected to be the most crucial season for job hunters, as a number of pharmaceutical companies that have recruitment plans like other industries are scheduled to employ new talents.
According to a po...
Sebivo demonstrated better antiviral activity compared to lamivudine in patients with hepatitis
Handok Pharm announced on March 9 new clinical data of Sebivo (telbivudine) for 24 weeks of treatment of chronic hepatitis B (CHB). Handok is a co-distributor of Sebivo in Korea.
Data from the second year of the ph...
Nutrition for your health concerns
Turning to health supplements is ideal for people of any age who are looking for additional support through naturally occurring ingredients.
Ideally, people would receive all of their required nutrition from the f...
Daewoong Bio to build 65 billion won plant in Kyunggi Province
Daewoong Bio says it will invest 65.0 billion won to build a cGMP plant producing a variety of pharmaceutical raw materials.
“To expand our production capacity of export-oriented pharmaceutical bulks, including UDC...
Korea Bone Bank to commercialize bone-regenerating protein
Korea Bone Bank a Seoul-based medical device maker, expects the company to be a global player in the emerging market for bone morphogenetic proteins (BMPs), known for their ability to stimulate the production of new b...
KFDA issues second safety alert on diabetes drug Avandia
The Korea Food and Drug Administration (KFDA) has recently issued another warning on GlaxoSmithKline's blockbuster diabetes drug Avandia after studies found an increase in heart-related deaths among patients taking th...
